Interference with pre-B-cell receptor signaling offers a therapeutic option for TCF3-rearranged childhood acute lymphoblastic leukemia.

ABSTRACT:

SUBMITTER: van der Veer A 

PROVIDER: S-EPMC3944663 | biostudies-literature | 2014 Feb

REPOSITORIES: biostudies-literature